Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 657 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Iowa City IA
Sponsor: Kittika Poonsombudlert

Sex: All

Age: 18 - 70+

Code: NCT07177079

Phase1, Recruiting

Ascorbate in Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: Iowa City IA
Sponsor: Prajwal Dhakal

Sex: All

Age: 18 - 70+

Code: NCT07283900

Phase2, Recruiting

Effects of Creatine Supplementation on Cognitive Measures and Markers of Acute Kidney Injury After Exercise in the Heat

for
Acute Kidney Injury, Exertional Heat Illness
Location: Cedar Falls IA
Sponsor: University of Northern Iowa

Sex: All

Age: 18 - 45

Code: NCT07472426

Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Fairfax VA, Atlanta GA, Nashville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07266441

Phase2, Recruiting

Glaucoma Related Quality of Life

for
Glaucoma
Location: Iowa City IA
Sponsor: Marc Toeteberg-Harms

Sex: All

Age: 18+

Code: NCT07510087

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

for
Hearing Loss, Bilateral Sensorineural
Location: New York NY, Miami FL, Beachwood OH, Novi MI,
Sponsor: Cochlear

Sex: All

Age: 18+

Code: NCT07287124

Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase2, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for
Advanced Renal Cell Carcinoma (RCC)
Location: Hauppauge NY, Baltimore MD, Washington D.C. DC,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07293351

Phase1, Phase2, Recruiting

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

for
Malignant Glioma
Location: Iowa City IA
Sponsor: John M. Buatti

Sex: All

Age: 21+

Code: NCT07447531

Recruiting

Rigorous Evaluation of Let's Talk Birth Control

for
Sexual Behavior, Adolescent Behavior
Location: Mentor OH, Sioux City IA
Sponsor: Child Trends

Sex: Female

Age: 15 - 24

Code: NCT06670066

Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Halifax, Farmington CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

for
Carcinoma, Non-Small-Cell Lung
Location: White Plains NY, Schenectady NY, Montreal, Newark DE,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06875310

Phase3, Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06998940

Phase3, Recruiting

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

for
Hepatitis
Location: Manhasset NY, Baltimore MD, Hershey PA, Richmond VA,
Sponsor: Bausch Health Americas, Inc.

Sex: All

Age: 18+

Code: NCT07428538

Phase3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

for
Overweight, Obesity
Location: Boston MA, Waltham MA, New Haven CT, Waterbury CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07392190

Phase3, Recruiting

Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility

for
Schizophrenia,
Location: Iowa City IA
Sponsor: Kai Hwang

Sex: All

Age: 18 - 35

Code: NCT07217652

Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Norfolk VA, Silver Spring MD, Fairfax VA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

Real-time Personalized Brain State-dependent TMS After Stroke

for
Stroke
Location: Iowa City IA
Sponsor: Sara Hussain

Sex: All

Age: 18+

Code: NCT06533176

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Uniondale NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase3, Recruiting

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

for
Acute Myeloid Leukaemia (AML), Follicular Lymphoma ( FL)
Location: York PA, Bethesda MD, Charlotte NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 0+

Code: NCT07154823

Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa